Published in Pediatr Dev Pathol on May 24, 2002
Is human cytomegalovirus a target in cancer therapy? Oncotarget (2011) 1.04
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases. J Pediatr Hematol Oncol (2008) 0.97
Effects of ginsenosides rg1 on osteoblasts cultured with ti particles. Biomol Ther (Seoul) (2012) 0.77
Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. Cancer Cell Int (2017) 0.75
Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. J Clin Pathol (2006) 0.75
The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer (2007) 5.28
The genetic landscape of high-risk neuroblastoma. Nat Genet (2013) 4.71
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood (2011) 4.21
Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet (2013) 3.45
Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med (2004) 2.90
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov (2014) 2.64
Database of mRNA gene expression profiles of multiple human organs. Genome Res (2005) 2.11
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell (2011) 1.96
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res (2004) 1.96
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clin Cancer Res (2005) 1.86
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood (2013) 1.85
Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Res (2008) 1.84
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest (2009) 1.83
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. J Clin Invest (2012) 1.83
A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am J Hum Genet (2012) 1.81
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res (2007) 1.71
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet (2003) 1.59
Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. J Natl Cancer Inst (2011) 1.55
Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy. Pediatr Blood Cancer (2011) 1.53
Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo. Cancer Res (2009) 1.47
EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res (2011) 1.46
Disclosure of incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics (2013) 1.44
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. Mol Cancer Ther (2008) 1.44
Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO. Cancer Biol Ther (2008) 1.44
Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS One (2009) 1.40
The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study. J Pediatr Surg (2005) 1.39
Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res (2009) 1.37
Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia (2011) 1.37
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics (2004) 1.33
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. Cancer Res (2006) 1.32
Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein. Clin Cancer Res (2009) 1.26
Altered expression of cell cycle genes distinguishes aggressive neuroblastoma. Oncogene (2005) 1.26
Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun (2005) 1.24
Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors. Cancer Res (2008) 1.24
"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment. Curr Gene Ther (2009) 1.20
Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer (2009) 1.19
Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a. J Proteome Res (2010) 1.17
Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model. Mol Ther (2007) 1.15
Diagnostic classification of cancer using DNA microarrays and artificial intelligence. Ann N Y Acad Sci (2004) 1.15
Statistical issues in longitudinal data analysis for treatment efficacy studies in the biomedical sciences. Mol Ther (2010) 1.14
Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One (2011) 1.13
Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamide. Mol Ther (2008) 1.12
Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses. Cancer Gene Ther (2005) 1.11
Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb Perspect Med (2014) 1.10
Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn (2007) 1.10
An integrated cross-platform prognosis study on neuroblastoma patients. Genomics (2008) 1.10
microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clin Cancer Res (2009) 1.08
Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging. Mol Imaging Biol (2011) 1.08
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res (2006) 1.07
Combination of diaphragmatic eventration and microphthalmia/anophthalmia is probably nonrandom. Am J Med Genet (2002) 1.07
11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer (2003) 1.04
Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress. Curr Pharm Biotechnol (2012) 1.03
Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. Oncogene (2003) 1.02
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging. Pediatr Blood Cancer (2011) 1.02
Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models. Pediatr Blood Cancer (2005) 1.01
Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma. J Proteome Res (2010) 1.00
Inferring a tumor progression model for neuroblastoma from genomic data. J Clin Oncol (2005) 1.00
Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines. Genes Chromosomes Cancer (2004) 0.99
Tumor classification using phylogenetic methods on expression data. J Theor Biol (2004) 0.99
Oncolytic virotherapy reaches adolescence. Pediatr Blood Cancer (2010) 0.99
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Res (2013) 0.99
Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants. Pediatr Blood Cancer (2006) 0.98
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target. Clin Cancer Res (2012) 0.98
Towards ultrathick battery electrodes: aligned carbon nanotube-enabled architecture. Adv Mater (2011) 0.97
Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy. Clin Cancer Res (2010) 0.97
A compendium of canine normal tissue gene expression. PLoS One (2011) 0.97
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma. Cancer Biol Ther (2009) 0.96
Charge density waves in exfoliated films of van der Waals materials: evolution of Raman spectrum in TiSe2. Nano Lett (2012) 0.96
Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol (2003) 0.96
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene (2002) 0.95
Differential susceptibility of pediatric sarcoma cells to oncolysis by conditionally replication-competent herpes simplex viruses. J Pediatr Hematol Oncol (2002) 0.94
Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays. Bioinformatics (2004) 0.93
Clinicopathologic features of a second patient with Ewing-like sarcoma harboring CIC-FOXO4 gene fusion. Am J Surg Pathol (2014) 0.91
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genomics (2011) 0.91
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Clin Cancer Res (2007) 0.91
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma. Genes Chromosomes Cancer (2006) 0.90
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies. PLoS One (2012) 0.89
The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia (2012) 0.89
Differing approaches to experimental therapeutics: are we a world apart? Mol Ther (2012) 0.89
Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. Cancer Res (2012) 0.89
Effect of dietary advanced glycation end products on mouse liver. PLoS One (2012) 0.89
High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma. Cancer Lett (2005) 0.88
Magnetic resonance urography in the evaluation of prenatally diagnosed hydronephrosis and renal dysgenesis. J Urol (2006) 0.88
Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer (2004) 0.87
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorg Med Chem Lett (2013) 0.87
Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts. J Pediatr Hematol Oncol (2003) 0.87
Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma. Cancer Res (2011) 0.87
Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers. Front Oncol (2012) 0.86
Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534). PLoS One (2013) 0.86
Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma. Pediatr Blood Cancer (2014) 0.86
Analyzing array data using supervised methods. Pharmacogenomics (2002) 0.85
Whole chromosome alterations predict survival in high-risk neuroblastoma without MYCN amplification. Clin Cancer Res (2008) 0.85
Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma. BMC Cancer (2012) 0.85
Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1. J Clin Microbiol (2004) 0.84
High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery. Cancer Invest (2012) 0.83
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group. Pediatr Blood Cancer (2014) 0.83
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. Mol Ther (2013) 0.83
Expression profiling identifies epoxy anthraquinone derivative as a DNA topoisomerase inhibitor. Cancer Lett (2010) 0.83
EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model. J Surg Res (2011) 0.82